TY  - JOUR
AU  - Navas, Natalia
AU  - Hermosilla, Jesús
AU  - Torrente-López, Anabel
AU  - Hernández-Jiménez, José
AU  - Cabeza, Jose
AU  - Pérez-Robles, Raquel
AU  - Salmerón-García, Antonio
PY  - 2020
DO  - 10.1016/j.jpha.2020.06.003
UR  - https://hdl.handle.net/10668/26091
T2  - Journal of pharmaceutical analysis
AB  - COVID-19, a disease caused by the novel coronavirus SARS-CoV-2, has produced a serious emergency for global public health, placing enormous stress on national health systems in many countries. Several studies suggest that cytokine storms...
LA  - en
KW  - COVID-19
KW  - Critical quality attributes
KW  - IV and SC medicines
KW  - Tocilizumab
TI  - Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes.
TY  - research article
VL  - 10
ER  -